OL Oncology Letters 1792-1074 1792-1082 D.A. Spandidos 10.3892/ol.2021.13152 OL-0-0-13152 Corrigendum Dihydroartemisinin suppresses proliferation, migration, the Wnt/β-catenin pathway and EMT via TNKS in gastric cancer MaYanmei ZhangPeng ZhangQilong WangXiaofei MiaoQiong LyuXiaolan CuiBo MaHonghong 01 2022 30 11 2021 23 1 34 Copyright: © Ma et al. 2021 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.

Oncol Lett 22: Article no. 688, 2021; DOI: 10.3892/ol.2021.12949

Following the publication of this article, the authors have reaized that Table II was printed containing certain numerical errors, although these were not significant enough to have affected the statistical results.

The corrected version of Table II is shown on the next page, and the corrected data (concerning the ‘Depth of invasion’, Lymph metastasis’, ‘TNM stage’ and ‘Survival status’ data rows) are highlighted in bold. The authors are grateful to the Editor of Oncology Letters for allowing them the opportunity to publish this corrigendum, and all the authors agree to this corrigendum. Furthermore, the authors apologize to the readership for any inconvenience caused.

Association between TNKS expression and the clinicopathological characteristics of patients with gastric cancer (n=87).

TNKS expression
Characteristic Total (n=87) Positive, % (n=61) Negative, % (n=26) χ2 P-value
Sex
  Male 42 28 (66.7) 14 (33.3) 0.461 0.497
  Female 45 33 (73.3) 12 (26.7)
Age, years
  <60 43 32 (74.4) 11 (25.6) 0.752 0.386
  ≥60 44 29 (65.9) 15 (34.1)
BMI
  <24 27 17 (63.0) 10 (37.0) 0.978 0.613
    24-27.9 31 23 (74.2) 8 (25.8)
  ≥28 29 21 (72.4) 8 (27.6)
Smoking
  No 46 33 (71.7) 13 (28.3) 0.123 0.726
  Yes 41 28 (68.3) 13 (31.7)
Drinking
  No 39 24 (61.5) 15 (38.5) 2.481 0.115
  Yes 48 37 (77.1) 11 (22.9)
Helicobacter pylori infection
  No 54 37 (68.5) 17 (31.5) 0.173 0.677
  Yes 33 24 (72.7) 9 (27.3)
Depth of invasion
  T1/T2 39 22 (56.4) 17 (43.6) 6.336 0.012a
  T3/T4 48 39 (81.2) 9 (18.8)
Lymph metastasis
  N0 26 12 (46.2) 14 (53.8) 10.160 0.001b
  N1/N2/N3 61 49 (80.3) 12 (19.7)
TNM stage
  Ⅰ-II 40 23 (57.5) 17 (42.5) 5.623 0.018a
  III-IV 47 38 (80.9) 9 (19.1)
Survival status
  Dead 33 31 (93.9) 2 (6.1) 14.402 <0.001c
  Alive 54 30 (55.6) 24 (44.4)

P<0.05;

P<0.01;

P<0.001. TNKS, Tankyrases; TNM, tumor-node-metastasis.